Julien de Salaberry is the Founder and CEO of Galen Growth Asia, whose mission is to build a sustainable and vibrant HealthTech ecosystem across Asia by scaling digital health innovation through industry partnerships.
He has over 15 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, Merck&Co., and he has a deep understanding of healthcare in both developed and emerging markets.
In 2012, he founded The Propell Group (TPG), a boutique venture investor firm, based in Singapore, which focuses on HealthTech startups and growth companies. Since 2012, TPG has invested in 23 companies including 4 successful exits.
In this episode of the Talking HealthTech podcast, Pete and Julien talk about the key trends in Asia Pacific HealthTech, and some of the exciting technologies coming out of Asia solving big health problems. Julien also deep dives into some of the more macro issues impacting healthtech in Asia at the moment such as the US/China trade war, and the United Nations Sustainable Health Goals for 2030.